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Introduction
Tubo-ovarian abscess (TOA) is one of the most
common causes of pelvic masses in reproductive-age
women (1) and it is a serious sequelae of acute pelvic
inflammatory disease (PID) (2).
The incidence of tuboovarian abscess is expected to
increase as a result of the current epidemic of sexually
transmitted disease and their sequelae (3). As a result
of the rising incidence of sexually transmitted disease,
such as gonorrhea, chlamydia and the widespread use
of intrauterine contraceptive devices, the problem of
both acute and chronic salpingitis (PID) remains a
major health concern (3).
These abscesses usually occur in sexually active
women between the ages of 20-40 years (1). Risk
factors for TOA are similar to those for PID, such as
multiple sexual partners, prior history of PID, no contraceptive use, intrauterine device (IUD) use and low
socioeconomic status (4).
The parity of these patients is variable with approximately 25% to 50% being nulliparous (3).
Abdominal or pelvic pain is the most frequent presenting complaint in more than 90% of cases of tuboovarian abscess reported in the literature (3). Patients
with TOA typically present with a history of abdominal
or pelvic pain, which may or may not include fever
(>38.5˚C) and chills (1). Laboratory data of patients
with TOAs are nonspecific. Despite the surgically confirmed presence of a TOA, 35% of patients were afebrile and 23% of patients had a normal leukocyte
count on admission in one study (1). Physical examina-
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tion may reveal lower abdominal tenderness, often
with peritoneal signs such as guarding and rebound
tenderness. Excess cervicovaginal secretions and evidence of cervicitis can be found on pelvic examination
(1).
In two years (1994-1995), at gynecology clinic of
Dr. Zekai Tahir Burak Women’s hospital, twenty-one
patients were diagnosed as having tubo ovarian abscess. These cases were evaluated retrospectively for
risk factors and clinical diagnosis. The patients ranged
from 19 to 41 years of age with a mean of
30.8±5.7 years SD. The parity of these patients were
variable. Their parity were between 0-7 with a mean
of 3.5 ± 1.7 SD. Three of the twenty-one patients
were observed as nulliparous (%14). Abdominal pain
was the most frequent complaint, which we have seen
in 85% of our cases of TOA. Other complaints were
foul smelling vaginal discharge (47%), vaginal bleeding
(28.5%). Physical examination revealed lower abdominal tenderness for most of the patients but rebound tenderness were found in five cases of the
twenty-one patients. Most of the patients had subfebrile fever, just three of them had fever more than
38.5˚C. Ultrasound examination correctly identified a
TOA in eighteen of twenty one patients. In our study
risk factors for TOAs were colpotomy operation due
to prior history of pelvic inflammatory disease (4.7%),
septic abortion ((4.7%), prior history of laparoscopically tubal ligation (9.5%), IUD usage (33.3%).Fifteen
of the twenty-one patients responded to clindamycin,
aminoglycoside treatment. Two of the twenty-one patients with medical treatment resistant dysfunctional
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uterine bleeding were treated with total abdominal
hysterectomy and bilateral or unilateral oophorectomy.
Both cases were in late reproductive years without
further desire of conception. One of the twenty one
patients who did not respond to medical treatment,
we performed posterior colpotomy plus abscess drainage following laparotomy.
The pathogenesis of
fully (1). Although TOA
PID, many women have
vic infections or sexually

TOA has not been elucidated
are often a sequelae of acute
no antecedent history of peltransmitted disease (1).

The initiating event in the formation of a TOA is
believed to be the invasion of fallopian tube epithelium
by a pathogen causing tissue damage and necrosis,
thereby providing an ideal environment for anaerobic
invasion and growth (1). In our study, history of PID
was found in three of the twenty-one patients. A
number of studies, however have shown that a prior
history of PID is obtained in only one third to one
half of patients presenting with tuboovarian abscess
(1,3). This may indicate that subclinical infections assessed the sensitivity of ultrasound in the detection of
pelvic abscesses to be 93% and the specficity 98.6%
(1). Our results were similar to the other series, ultrasound examination was correctly identified a TOA in
eighteen of the twenty-one patients (85%).
The management of TOA changed dramatically after the development of broad spectrum antibiotics. Because most women with TOA are in their reproductive
years, the usual and accepted approach is conservative;
either medical, surgical or a combination of the two,
to preserve fertility (1).

The treatment regimens must include antimicrobial
agents that have appropriate coverage against organisms commonly found in TOA. Medical therapy also reduces the added morbidity of surgery. In addition to
the preservation of fertility, conservative therapy maintains endogenous ovarian steroid production (1). With
medical treatment, Landers et al and Sweet et al had
excellent clinical cure rates of 90-100% (1,5). Harold
et al currently recommend either a combination of
clindamycin plus aminoglycoside or cefoxitin plus doxcycline as conservative therapy for TOA (1). In our institution, we used clindamycin plus aminoglycoside
with cure rate of 71.4%. Landers et al treated their
patients with clindamycin plus aminoglycoside, and
their cure rates were 72-73% respectively (5). Our
results were similar to these studies. It appears that
clindamycin plus aminoglycoside combination is an effective regimen in the conservative treatment of sonographically or laparoscopically confirmed TOA.
There are three main indications for surgical intervention
in
patients
with
suspected
TOA;
1.Intraabdominal rupture. 2.High index of suspicion of
other surgical emergencies, such as appendicitis.
3.Failure to respond antibiotic therapy within 48-72
hours (1).
Surgical therapy is necessary in approximately 25%
of patients treated for TOA (1). In our study, we performed surgical therapy in 28.5% of our patients
treated for TOA. On the other hand the size of the
TOA may influence the decision or timing of the surgery. Harold et al reported that TOA larger than 8 cm
were less likely to respond to antimicrobial treatment
than smaller abscesses (1).
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